1 not yet recruiting, 1 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department Haloperidol - Cannabinoid Hyperemesis Syndrome | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 100 | 2026-11-01 | 2026-09-01 |
| Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1) JWK010 gene therapy - Oculocutaneous Albinism (OCA) | Early Phase 1 | Recruiting | West China Hospital | 18 | 2025-12-22 | 2026-01-12 |
Albinism, Oculocutaneous (1) · Cannabinoid Hyperemesis Syndrome (1) · Chediak-Higashi Syndrome (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Amino Acid Metabolism, Inborn Errors (1) · Chemically-Induced Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hypopigmentation (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Leukocyte Disorders (1) · Marijuana Abuse (1) · Mental Disorders (1)
Haloperidol (1)
University of Illinois at Chicago (1) · West China Hospital (1)
China (1) · United States (1)
Fang Lu (1) · Wesley Eilbert, MD (1)